Running Team to raise support for EORTC cancer research at Belfius Brussels Marathon
21 Aug 2015
The EORTC Running Team plans to participate in the Belfius Brussels Marathon and Half Marathon on Sunday, 4 October 2015. This is an event that gladly supports organizations such as the EORTC who participate in order to benefit a good cause (FR, NL, EN).
The proceeds raised by Team EORTC will go towards supporting EORTC projects that improve treatments for patients with cancer. Please feel free to join the team, and you can support them and the EORTC with your donation.
The races at Belfius Brussels Mathon and Half Marathon include not only the marathon and half marathon, but also a 5km run and a one kilometer chiquita kids run. The EORTC Running Team anticipates that 10 -15 members of the EORTC Headquarters staff will take part in this event.
The EORTC Running Team has already participated in several other events in the past, e.g. the Brussels Marathon 2014, La Bruxelloise – Urban Woman Jogging, the Antwerp 10 miles & Marathon, the 20 km Brussels, the Brussels urban trail, etc., and is eager to welcome new members to join the fun.
Whether you are a child or a senior, a walker or a marathoner, you can take part in their program, and you can also count on seeing Team EORTC continue their efforts by participating in future events. As an added bonus, team members are provided dry-fit EORTC t-shirts.
Team EORTC points out that exercise is one of twelve ways to reduce your cancer risk as listed in the European Code Against Cancer.
John Bean, PhD
EORTC, Medical Science Writer
Related News
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
Independent, academic cancer trials are vital to improve patient outcomes worldwide
28 Apr 2026
EORTC Imaging Group Becomes the Diagnostic and Therapeutic Imaging Group
24 Apr 2026
